Source: iQoncept / Shutterstock
Gyre Therapeutics (NASDAQ:GYRE) just reported results for the first quarter of 2024.
- Gyre Therapeutics reported earnings per share of 3 cents.
- The company reported revenue of $27.17 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/gyre-stock-earnings-gyre-therapeutics-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC